Biomarkers for NASH Symposium: Most Anticipated Presentation
In anticipation of our Biomarkers for NASH Symposium event happening on 07 December 2022, we look at 3 of the most anticipated presentations.
Biomarkers For NASH Symposium features cutting-edge sessions and knowledge sharing, including over 20 presentations, case studies, and discussions taking place across the event.
The one-day symposium encompasses emerging trends in the application of technology in developing treatments, regulatory updates, and includes a focus on the importance of improving preclinical and translational models for NASH.
With a high-quality program devised with the help of our esteemed advisory board, not-to-miss sessions will include:
1.) 'A Novel SiRNA Mitochondrial Regulator for the Treatment Of NASH/Liver Disease'
• Efficacy demonstrated in multiple disease models
• Target validated by assessing liver biopsy samples from patients
• PK/PD and toxicology studies ongoing
Cynthia Arbeeny, Chief Scientific Officer at Mitotherapeutix
2.) 'Analytical Approaches To The Development Of NASH Biomarkers'
• Background on the FDA Biomarker Qualification Program
• The important analytical considerations for NASH biomarkers
• The presentation will cover the NASH biomarker received and future considerations
Abbas Bandukwala, Science Policy Analyst Biomarker Qualification Program at U.S. Food and Drug Administration
3.) Panel Discussion: ‘The Translation of Biomarkers and Applications in the Clinic’
• Challenges in translation - validation and biomarker discovery
• Marker development in patient treatment
• Disease monitoring and diagnostics
Panel Members:
Abbas Bandukwala, Science Policy Analyst Biomarker Qualification Program at U.S. Food and Drug Administration
Tania Kamphaus, Director, Metabolic Disorders at Foundation for the National Institutes of Health
The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future.
Sign up for the brochure HERE and register HERE today.
For more information on Oxford Global’s Biologics 2022 event series, visit: https://oxfordglobal.com/biomarkers/
.jpg)
